去纤苷在哪里买比较靠谱?
Where can I buy defibrotide more reliably
1. Hospital pharmacies: Usually the pharmacies of large hospitals will have it, and you can go directly to the pharmacy for consultation and purchase. Patients can go to hospitals in countries where defibrotide is listed, and the doctor can buy it directly in the hospital pharmacy after issuing a prescription.
2. Pharmacies: Defibrotide can be purchased at professional pharmacies or chain pharmacies in countries where defibrotide is listed. A medical prescription is usually required before purchase.
3. Online pharmacies: Some officially authorized online pharmacies may also sell defibrotide, but you need to ensure the authenticity and credibility of the website when purchasing.
4. Medical institutions: Since defibrotide is not yet on the market in China, some patients may need to purchase it through domestic medical institutions. Regular medical service institutions can usually ensure that the source of drugs is legal and the quality is guaranteed.
Notes on purchasing defibrotide
1. Check whether the packaging and labels of the medicine are complete and clear, and there are no spelling errors or unclear handwriting.
2. Check the batch number and production date on the medicine to ensure that it is consistent with the medicine purchased through regular channels.
3. Confirm the storage conditions of the drug. Defibrotide should be stored within the temperature range of 20°C-25°C and stored in a dry and dark place.
Patients should choose regular ones to ensure the authenticity and safety of the drugs. At the same time, since the price of defibrotide may be affected by a variety of factors, please refer to the actual purchase time for the specific price.
How to administer defibrotide
The recommended dose of defibrotide for adult and pediatric patients is 6.25 mg/kg every 6 hours, intravenously infused over 2 hours, and treatment should continue for at least 21 days. If signs/symptoms of hepatic veno-occlusive disease do not resolve after 21 days, treatment may be continued until the hepatic veno-occlusive disease resolves or for up to 60 days.
In the event of severe or life-threatening hypersensitivity reactions and repeated massive bleeding, defibrotide should be permanently discontinued. If bleeding is persistent, severe, or potentially life-threatening, treatment should be discontinued and the cause of bleeding should be treated.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)